Financial Data and Key Metrics Changes - Total revenue for Q3 2025 reached $169.7 million, up 173.6% year-over-year and up 9.1% sequentially [4][17] - Gross profit was $40.8 million, with a gross margin of 24.1%, compared to 4.5% in Q3 2024 and 8.2% in Q2 2025 [17][18] - Adjusted EBITDA increased to $43 million, a significant improvement from negative $7.9 million in Q3 2024 [20] - Net loss for the quarter was $266.7 million, compared to $50.1 million in Q3 2024 [19][23] Business Line Data and Key Metrics Changes - Self-mining revenue was $130.9 million, up 315.6% year-over-year, driven by a 273.1% increase in self-mining hash rate [17][20] - Seal Miner sales revenue was $11.4 million, compared to $0 in Q3 2024 [17] Market Data and Key Metrics Changes - The average operating self-mining hash rate increased to 29.1 EH/s, with a further increase to 41.2 EH/s by the end of October [5][6] - The company expects continued improvement in energy efficiency across its fleet, which will enhance margins and profitability [6] Company Strategy and Development Direction - Bitdeer is transitioning from a Bitcoin mining leader to a vertically integrated Bitcoin infrastructure and AI platform [4] - The company plans to focus on three strategic pillars: Bitcoin mining, ASIC development, and HPC AI [7] - A shift towards developing data centers internally rather than through joint ventures was announced, allowing for greater flexibility and control [8][60] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing demand for AI compute and expects the supply-demand imbalance to persist into 2027 [12] - The company anticipates significant growth in its self-mining operations and AI cloud services, with a potential annualized revenue run rate exceeding $2 billion by the end of 2026 [12][20] Other Important Information - The company has fully energized its TDEL site in Norway and the 500 MW site in Jigmaling, Bhutan, increasing its total electrical capacity to approximately 1.6 GW [14] - A new 300 MW site in Niles, Ohio is on track for energization in Q1 2029 [15] Q&A Session Summary Question: Progression of HPC opportunity and expansion into the U.S. - Management confirmed simultaneous progress in Malaysia and the U.S. for AI cloud services [34] Question: Delay of the Seal 04 Miner chip - The delay is due to complexities in implementation and design changes, but confidence in the technology remains high [43][87] Question: Demand comparison between Norway and U.S. sites - Demand in Norway is driven by low power availability and the site's readiness for AI data center conversion, potentially higher than U.S. sites [51] Question: Financial options for HPC AI capacity development - Currently, there is no joint venture partner for HPC AI development, and the company is pursuing opportunities independently [60] Question: Customer base expectations for AI cloud revenue - The customer base is expected to be a mix of small to medium enterprises and larger customers, contributing to the projected revenue [74]

Financial Data and Key Metrics Changes - Total Payment Volume (TPV) grew by 18%, revenue increased by 10%, and net income rose by 12% [3] - Excluding the impact of smartphone supply issues, revenue would have increased by 32% and net income by 16% [3][4] - The fintech segment showed a 16% growth in Total Financial Volume (TFV) and a 24% increase in revenue [4][41] Business Line Data and Key Metrics Changes - Payments segment experienced a TPV growth of 18% and revenue growth of 10% [3][31] - Marketplace GMV grew by 12%, but would have been 20% without smartphone supply issues [3][34] - E-grocery business saw a GMV increase of 53% and transaction growth of 55% [7] - Advertising revenue grew by 56% year-over-year [13][38] Market Data and Key Metrics Changes - The smartphone supply disruption impacted GMV by approximately 8% and consolidated income by 3% [5][34] - The overall market environment is expected to improve as supply issues resolve, particularly for smartphones [6][34] Company Strategy and Development Direction - The company is focusing on enhancing its core business performance while navigating external challenges [6][49] - Plans to initiate a $400 million ADS buyback program to return cash to shareholders while investing in growth [4][49] - Emphasis on improving user experience and expanding advertising services to drive revenue growth [13][66] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about recovering demand in the next year despite current supply constraints [5][6] - The competitive landscape remains stable, with a focus on quality service delivery rather than traditional competition [56] - Future growth is anticipated as supply issues resolve and the company continues to innovate [34][48] Other Important Information - The company is integrating new payment options and enhancing its advertising capabilities to drive engagement [12][66] - The introduction of innovative payment methods, such as "Pay by Palm," is expected to enhance consumer experience [12][13] Q&A Session Summary Question: Updates on Hepsiburada and investment levels - Management highlighted the focus on quality products and user experience as key priorities for growth, with no significant need for capital investments anticipated [53][55] Question: Advertising product growth and potential - Management indicated strong growth in advertising services, with expectations for continued acceleration as the company enhances merchant experiences [57][59] Question: Marketplace take rate increase - The increase in take rate is driven by additional services such as advertising and delivery, rather than higher seller fees [64] Question: Smartphone supply impact and trends - Management confirmed ongoing supply constraints for new smartphone models, with expectations for improvement in the coming months [70][72]

Financial Data and Key Metrics Changes - In Q3 2025, orders reached 83.4 million, up 14% year over year, driving Gross Transaction Value (GTV) of $9.17 billion, up 10% year over year [22] - Average order value decreased by 4% year over year, primarily due to growth in restaurant orders and the introduction of a $10 basket minimum for Instacart+ members [22] - GAAP net income was $144 million, up 22% year over year, and adjusted EBITDA also grew 22% year over year to $278 million [23] - Operating cash flow increased by $102 million year over year to $287 million [23] - The company repurchased $67 million worth of shares in Q3 and ended the quarter with approximately $1.9 billion in cash and similar assets [23] Business Line Data and Key Metrics Changes - The marketplace continues to be the backbone of the business, with a growing and loyal customer base, leading to increased order frequency and customer retention [7][8] - Advertising and other revenue grew 10% year over year, representing 2.9% of GTV, which was effectively flat year over year [23] - The enterprise platform is a key growth driver, with over 350 retailer e-commerce storefronts powered by the company’s technology [10][14] Market Data and Key Metrics Changes - The company is seeing strong demand in October, with continued momentum from enterprise partnerships [24][52] - The advertising ecosystem has diversified, with partnerships established with platforms like TikTok and Pinterest, enhancing the overall advertising capabilities [16][44] Company Strategy and Development Direction - The company aims to enhance affordability, accelerate enterprise growth, and innovate in the advertising space [31][32][33] - The enterprise platform is seen as a strategic growth lever, with opportunities for cross-selling additional solutions to existing partners [14] - The company is focused on international expansion, particularly in Europe and Australia, leveraging existing products [19][50] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's strength and the ability to drive sustainable growth in the short, medium, and long term [19][20] - The company is committed to disciplined execution and increasing profitability, with a guidance for Q4 adjusted EBITDA of $285-$295 million [25][26] - Management acknowledged the challenges in the macro environment but remains optimistic about returning advertising revenue to double-digit growth in 2026 [25][42] Other Important Information - The company launched a suite of AI products aimed at helping retailers gain a competitive advantage [12][13] - A $1.5 billion increase to the share repurchase program was authorized, reflecting confidence in long-term value creation [20][26] Q&A Session Summary Question: What are the biggest strategic investments for growth? - Management highlighted three focus areas: affordability, accelerating enterprise growth, and enhancing the advertising ecosystem [30][31][33] Question: How will AI solutions be monetized? - AI solutions will be offered as enterprise capabilities, enhancing operations and customer experiences for retail partners [40] Question: What is the impact of new partnerships and international growth plans? - New partnerships are expected to drive significant growth, with a disciplined approach to international expansion [49][50] Question: How does the competitive environment affect pricing strategies? - Management noted that retailers are aware of competitive dynamics and are testing price parity pilots to remain competitive [72] Question: What is the contribution of enterprise solutions to overall business? - Enterprise solutions are critical for order density and cost-to-serve advantages, reinforcing both marketplace and enterprise growth [78][80]

Financial Data and Key Metrics Changes - The company reported a loss from continuing operations, net of tax, of $166 million for the quarter [23] - Cash and cash equivalents stood at $4.4 billion, with no debt on the balance sheet, indicating a strong capital position [23][24] Business Line Data and Key Metrics Changes - The company has initiated potentially registrational trials in multiple indications, including Graves' disease, myasthenia gravis, CIDP, and others, indicating a robust pipeline [6][8] - The NDA filing for BREPO is on track for the first half of next year, which is expected to be the first novel oral therapeutic in dermatomyositis if approved [4][10] Market Data and Key Metrics Changes - The patient population for Graves' disease is significant, with approximately 880,000 diagnosed patients in the U.S., highlighting a large unmet medical need [18] - The company noted that 75% of dermatomyositis patients are currently on either steroids or immunosuppressive therapies, indicating a substantial market opportunity for new treatments [10][11] Company Strategy and Development Direction - The company is focused on expanding its late-stage pipeline, with 11 potentially registrational trials and indications with blockbuster potential [7][8] - The management emphasized the importance of addressing the unmet needs in various disease areas, particularly in Graves' disease and dermatomyositis, as part of their strategic direction [16][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the upcoming investor day on December 11, where they plan to provide more insights into the company's future and strategic direction [3][24] - The competitive landscape in Graves' disease is evolving, with other companies entering the space, but management believes their product has a strong competitive profile [32][63] Other Important Information - The company has a favorable marketing ruling in the Pfizer case and is making progress in the LNP litigation, with a jury trial in the Moderna case scheduled for March 2026 [6][23] - The company is considering various strategies for FDA approval and patient access for BREPO, reflecting a proactive approach to market entry [56] Q&A Session Summary Question: What should be watched next regarding Pfizer litigation? - Management indicated that the scheduling process for the Pfizer case is underway, and more information about the timeline, including a potential trial date, will be available soon [27][28] Question: How does Argenx stepping into Graves affect the strategy for 1402? - Management acknowledged the competitive landscape but expressed confidence in their data and the significant patient population, suggesting that increased competition could benefit all players in the space [31][33] Question: What to expect from the investor day? - Management stated that the investor day will focus on the transformation of the business and may include new data or strategic updates [35][36] Question: Can you clarify the impact of high-dose batoclimab on remission rates in Graves' disease? - Management noted that deeper IgG reductions are expected to drive better outcomes, and they are optimistic about the data from the ongoing studies [41][44] Question: What is the status of the TED study and its competitive landscape? - Management highlighted the competitive intensity in TED and indicated that they are looking forward to data that will inform their development strategy [82][83]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $2.3 billion, representing a 10.5% increase on a reported basis and an 8% increase on a like-for-like basis, reflecting strong underlying growth across segments [13][19] - Net income decreased due to a $10 million loss in discontinued operations and an $8 million non-cash fair value charge, partially offset by $10 million in insurance proceeds and higher earnings in equity method investments [13][19] - Adjusted EBITDA decreased by $1.3 million, primarily due to declines in the fresh fruit segment, while adjusted net income decreased by $3 million [14][19] Business Line Data and Key Metrics Changes - Fresh fruit revenue increased by 11%, driven by higher volumes and pricing of bananas, pineapples, and plantains, but faced higher sourcing costs leading to decreased adjusted EBITDA [15][16] - Diversified EMA segment reported an 11% revenue increase, with adjusted EBITDA rising by $10 million or 34%, driven by strong performance in Scandinavia, Spain, and the Netherlands [16][10] - Diversified Americas segment saw an 8% revenue increase, with adjusted EBITDA up by $4 million or 46%, attributed to strong performance in the southern hemisphere export business and North American market [16][11] Market Data and Key Metrics Changes - Demand for bananas remained robust in North American and European markets, contributing to tight supply and cost pressures [10][9] - The company is experiencing strong underlying growth in key markets, particularly in Spain and the Netherlands, with positive momentum continuing into Q4 [10][11] Company Strategy and Development Direction - The company completed the sale of its non-core fresh vegetable division, enhancing capital allocation flexibility and allowing for a $100 million share repurchase program [5][6] - The launch of the new Dole Collada Royale Pineapple aims to provide a competitive edge and stimulate excitement in the tropical category, reinforcing the company's commitment to community support [8][9] - The company is focused on integrating operations and streamlining its business model to enhance efficiency and attractiveness to key customers [57][56] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year adjusted EBITDA at the upper end of the targeted range of $380-$390 million despite macroeconomic volatility and industry-specific challenges [20][19] - The company is optimistic about the future, with ongoing negotiations for annual contracts and a strong consumer demand for affordable and healthy products [59][53] Other Important Information - Cash capital expenditure for the quarter was $20.9 million, with a reduction in full-year routine capital expenditure expectations to approximately $85 million [17][18] - The company declared an $8.50 dividend for Q3, to be paid on January 6th [19][18] Q&A Session Summary Question: Outlook for Q4 and 2026 - Management acknowledged the challenges in forecasting due to macroeconomic volatility and highlighted specific headwinds impacting procurement costs, particularly in the banana segment [25][26] Question: Tariffs and Exclusions - Management stated there is no new information regarding tariff exclusions for tropical produce, but expressed confidence in future positive changes [28][29] Question: Capital Allocation and Buyback Program - The $100 million buyback program is part of a broader capital allocation strategy, allowing for flexibility in pursuing growth opportunities while maintaining a progressive dividend policy [39][38] Question: Annual Contracting Negotiations - Management indicated that negotiations are ongoing and that customers are aware of supply challenges, expressing optimism about the outcomes [53][52] Question: Strength in Diversified Fresh Produce - Management highlighted the strong market position in Europe and North America, emphasizing the benefits of integrating operations and investments in distribution capabilities [56][57]

Financial Data and Key Metrics Changes - Revenue rose 36.7% year-over-year to $49.3 million in Q3 2025, with a 29% increase excluding Keystone [11][12] - Medical segment-adjusted EBITDA margin increased to over 15% in Q3 2025, compared to 10.8% in the prior year period [6][12] - Free cash flow from continuing operations was approximately $2 million in the quarter, with expectations for consistent free cash flow generation moving forward [14][17] Business Line Data and Key Metrics Changes - Organ placement services revenue more than doubled year-over-year, indicating strong growth in this segment [11] - Keystone contributed $2.8 million in revenue for half a month, with a full month revenue increase of over 40% year-over-year [12] - The medical segment-adjusted EBITDA margins improved sequentially to 15.1% in Q3 2025, driven by better performance in the fleet [12] Market Data and Key Metrics Changes - Industry-wide NRP adoption rates continued to increase during Q3, with transplants of organs that have undergone NRP approximately doubling versus the prior year [9] - Despite a seasonal decline in industry transplant volumes of approximately 6%, the company achieved a 3% sequential revenue increase [11] Company Strategy and Development Direction - The company has rebranded as Strata Critical Medical and shifted focus to healthcare, aiming for long-term growth and value creation [5] - The integration of Keystone and the launch of a new clinical services division positions the company as an end-to-end organ recovery platform [8] - The strategy includes co-locating resources to reduce costs and improve service delivery efficiency [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong demand seen in Q3, leading to an increase in 2025 revenue guidance to $185 million-$195 million [17] - The company anticipates continued growth driven by new technology and evolving regulations in the transplant industry [23] - Management noted that the seasonal decline in transplant volumes is expected and has been historically observed, but the company is growing through this seasonality [40] Other Important Information - The company ended the quarter with no debt and approximately $76 million in cash and short-term investments [16] - A legal provision was booked during the quarter for ongoing litigation related to the go-public transaction [17] Q&A Session Summary Question: Can you provide a disaggregation of where the growth came from in terms of revenue during Q3? - Management indicated that growth was a mix of new customer acquisition and strength within existing customers, with a broadened suite of services contributing to revenue growth [21][22] Question: Do you see the growth coming from similar directions in the future? - Management expects continued customer acquisition and market share consolidation, supported by a favorable industry growth trajectory [23] Question: What should be expected in terms of fleet margin and maintenance impact? - Management noted that scheduled maintenance events have decreased and margins are expected to improve sequentially [24] Question: How many individual customers are being served now post-Keystone acquisition? - Management stated that there are almost 250 different customers across the cardiac care and transplant businesses, providing geographic diversity [30] Question: Is there any customer that constitutes 5% or more of revenues? - Management did not disclose specific customer revenue contributions but emphasized a diversified customer base [31] Question: Will there be a breakdown of logistics versus perfusionist services? - Management indicated that a pro forma 2025 business mix will be provided, reflecting the expected shift towards fast-growing subsectors of the transplant industry [35][36]

Financial Data and Key Metrics Changes - Total Payment Volume (TPV) grew by 18%, revenue increased by 10%, and net income rose by 12% year-over-year [3][4] - Excluding the impact of smartphone supply issues, GMV growth would have been 20%, with revenue up 32% and net income growth at 16% [3][4][5] - The fintech segment reported a 16% growth in Total Financial Volume (TFV) and a 24% increase in revenue [4][41] Business Line Data and Key Metrics Changes - Payments segment showed robust growth with TPV up 18% and revenue growth of 10% [31][32] - Marketplace GMV grew by 12%, but would have been 20% without smartphone supply disruptions [33][34] - E-grocery business saw a GMV increase of 53% and transaction growth of 55% [7][8] - Advertising revenue grew by 56% year-over-year, indicating strong performance in the marketplace [13][38] Market Data and Key Metrics Changes - The smartphone supply disruption had an 8% impact on GMV and a 3% impact on consolidated income [5][6] - The competitive position in e-commerce remains strong, with expectations for recovery as supply issues resolve [35][36] - The travel segment's GMV grew by 13% in Q3, with a take rate increase of 50 basis points [37] Company Strategy and Development Direction - The company is focusing on enhancing user experience and product quality to drive growth [55][56] - Plans to expand the e-grocery business and integrate more banks into the payment platform [8][9] - The introduction of innovative payment methods, such as "Pay by Palm," aims to enhance consumer flexibility [12][13] Management's Comments on Operating Environment and Future Outlook - Management expects a favorable recovery in smartphone supply starting March 2026, which will positively impact growth [35][49] - The high-interest rate environment is anticipated to normalize, providing additional performance positives for the next year [6][42] - The company is optimistic about the growth potential in advertising services, which are expected to outpace other revenue streams [57][59] Other Important Information - The company announced a $400 million ADS buyback program to return cash to shareholders [4][49] - The introduction of new technologies, such as Kaspi Ai, aims to improve merchant experiences and drive sales [16][22] Q&A Session Summary Question: Updates on Hepsiburada and competitive environment in Turkey - Management emphasized the focus on high-quality products and user experience as key growth drivers, with no significant need for capital investments anticipated [55][56] Question: Insights on advertising product growth and potential - Management highlighted the development of a full range of advertising services, with expectations for faster growth than other revenue streams [57][59] Question: Clarification on marketplace take rate increase - The increase in take rate is driven by additional services such as advertising and delivery, rather than higher seller fees [64] Question: Current trends regarding smartphone supply impact - Management noted that supply remains constrained, particularly for new models, but expects a favorable comp starting in March 2026 [70][71]

Financial Data and Key Metrics Changes - Total revenues for Q3 2025 were $58.8 million, up from $37.4 million in Q3 2024, representing an increase of over $21 million [20] - Net product revenues increased to $56.8 million from $35.6 million year-over-year, driven by Vafseo sales of $14.3 million and Auryxia sales of $42.5 million, up from $35.6 million [20] - The company generated a net income of approximately $540,000 in Q3 2025, compared to a net loss of $20 million in Q3 2024 [24] Business Line Data and Key Metrics Changes - Vafseo generated $14.3 million in revenue this quarter, while Auryxia sales increased to $42.5 million [20] - The average dose of Vafseo refills increased by 5% compared to the previous quarter and 32% above the starting dose, indicating physicians are becoming more comfortable with optimal dosing [13] Market Data and Key Metrics Changes - The number of accessible patients for Vafseo increased from 40,000 at the beginning of the year to over 260,000 by the end of Q3 2025, with significant contributions from the DaVita pilot and other dialysis providers [17][19] - Over 85% of prescriptions written for Vafseo were refills, indicating a growing acceptance among prescribers [13] Company Strategy and Development Direction - The company aims to make Vafseo the standard of care for treating anemia in dialysis patients, supported by positive clinical data and strong prescriber interest [4][11] - The strategy includes addressing operational challenges and enhancing adherence through better education and support for prescribers [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in overcoming operational issues and increasing prescribing access, with expectations of significant growth in patient access by early 2026 [19][63] - The management highlighted the importance of ongoing data generation to support Vafseo's clinical differentiation and long-term growth [8][9] Other Important Information - The company is preparing for the results of the VOICE and VOCALE studies, which are expected to be important data catalysts for Vafseo [9] - Auryxia's future sales levels are uncertain due to potential generic competition, but the company continues to perform well in the market [21] Q&A Session Summary Question: What strategies could be used to overcome operational challenges for Vafseo? - The company is focusing on improving messaging around titration strategies and working closely with anemia managers to enhance adherence [26][27] Question: What has been the physician feedback regarding Vafseo's impact on hospitalization outcomes? - Physicians expressed excitement about the data presented, indicating that Vafseo could significantly change care for patients [34][35] Question: What are the greatest hurdles for expanding Vafseo in medium dialysis organizations? - The main hurdles include navigating operational processes at dialysis providers and ensuring adherence among patients [40][42]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 reached $169.7 million, representing a year-over-year increase of 173.6% and a sequential increase of 9.1% [4][16] - Gross profit was $40.8 million, with a gross margin of 24.1%, compared to 4.5% in Q3 2024 and 8.2% in Q2 2025 [16][17] - Adjusted EBITDA improved to $43 million, up from negative $7.9 million in Q3 2024 and positive $17.3 million in Q2 2025 [19] - Net loss for the quarter was $266.7 million, compared to $50.1 million in Q3 2024 and $147.7 million in Q2 2025 [18] Business Line Data and Key Metrics Changes - Self-mining revenue was $130.9 million, up 315.6% year-over-year and 120.7% sequentially, driven by a 273.1% year-over-year increase in self-mining hash rate [16][19] - Seal Miner sales revenue was $11.4 million, compared to $0 in Q3 2024 and $69.5 million in Q2 2025 [16] Market Data and Key Metrics Changes - The average operating self-mining hash rate increased to 29.1 exahash per second, with a target of 40 exahash per second achieved by the end of October 2025 [4][5] - The company operates 584 GPUs with an 87% utilization rate in its AI Cloud Services business, reaching an annualized revenue run rate of $8 million [6] Company Strategy and Development Direction - The company aims to transition from a Bitcoin mining leader to a vertically integrated Bitcoin infrastructure and AI platform, focusing on three strategic pillars: Bitcoin mining, ASIC development, and HPC AI [4][6] - Plans to develop data centers using an internal team and strategic hiring, moving away from a joint venture model due to increased market demand [8][9] - Expansion of AI cloud services into Malaysia, the U.S., and Europe is underway, targeting small to mid-sized enterprises and traditional U.S. customers [9][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth and efficiency improvements in the self-mining business, anticipating significant growth throughout 2026 [5][19] - The supply and demand imbalance for AI compute is expected to persist into 2027, with potential annualized revenue exceeding $2 billion from AI cloud services by the end of 2026 [12][19] Other Important Information - The company has a total available electrical capacity of approximately 1.6 gigawatts and a global power pipeline of about 3 gigawatts [14] - The company ended the quarter with $196.3 million in cash and cash equivalents, and $824.3 million in borrowings excluding derivative liabilities [22] Q&A Session Summary Question: Progression of HPC opportunity and expansion into the U.S. - Management confirmed simultaneous progress in Malaysia and the U.S. for HPC opportunities [25][26] Question: Details on the Niles, Ohio site acquisition - The Niles site was acquired a few months prior, providing long-term optionality for future developments [28] Question: Reason for the delay of the Seal 04 chip - The delay is due to complexities in implementation and design flow changes [30] Question: Demand comparison between Norway and U.S. sites - Norway's site is seeing high demand due to its low power availability and tier three data center readiness [32][33] Question: Financing options for HPC AI development - Currently, there is no joint venture partner; the company is pursuing development independently [36] Question: Customer base expectations for AI cloud services - The customer base is expected to be a mix of small to mid-sized companies and larger enterprises [40]

Financial Data and Key Metrics Changes - Total revenue reached $21.1 million, up 62% year-over-year, marking the third consecutive quarter of acceleration [11][12] - Adjusted EBITDA margin reached 40% in Q3, compared to 14% a year ago, excluding non-recurring items [15] - Net interest margin on margin loans improved 44 basis points to 1.63% [12][15] Business Line Data and Key Metrics Changes - Tech financing fee on supply chain loans reached $15.6 million, up 51% year-over-year, driven by strong hash rate loan growth [11] - Tech platform fee on margin loans roughly doubled year-over-year to $5.5 million [11] - Total loans facilitated on NLPaaS Prime reached $2.4 billion, up 60% year-over-year [12] Market Data and Key Metrics Changes - The number of institutional clients increased 28% year-over-year in Q3 [12] - Total value of loans (TVL) per customer on a 12-month rolling basis increased 55% year-over-year [12] Company Strategy and Development Direction - Company is focusing on globalization and the NLPaaS RWA hub as strategic priorities for growth [5][6] - The acquisition of Prestige Wealth, renamed Aurelion, is a pivotal milestone in the company's treasury strategy [9] - Aurelion aims to become a $10 billion Tether Gold DATT over time, enhancing the company's collateral resiliency [9][17] Management's Comments on Operating Environment and Future Outlook - Management expects fourth quarter revenue to range between $26 million and $28 million, representing 94%-109% growth year-over-year [15] - The company is leveraging its platform to drive sustainable revenue growth and expand margins while positioning for long-term global expansion [15][16] Other Important Information - The company facilitated a $206 million bridge loan to Nakamoto for their digital asset treasury [5] - Funding costs on supply chain loans declined to 5.18%, down 29 basis points from a year ago [12] Q&A Session Summary Question: Is the fourth quarter guidance assuming any benefit from Aurelion, or is it all organic? - Management clarified that they do not derive revenue from Aurelion; instead, Aurelion raises capital and lends gold to strengthen the company's balance sheet [21][22] Question: Can you expand on pricing power in the business? - Management noted that despite the Fed decreasing interest rates, they have maintained tech fees and improved margins due to branding power and scale [24] Question: What is the proper range for net interest margin, and what is the average loan per customer? - The average loan amount for supply chain loans is roughly $32 million, and for margin loans, it is approximately $47 million, both growing over 50% year-over-year [33]